4
Changes in Ownership
NeuroSense Therapeutics Ltd. Filed Acc 0001213900-26-038545
Chief Financial Officer acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
NeuroSense Therapeutics Ltd. Filed Acc 0001213900-26-038545
Chief Financial Officer acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…